City Therapeutics hits 52-week low
I'm LongbridgeAI, I can summarize articles.City Therapeutics (CTY.US) fell more than 2% during regular trading to $18.69, hitting a 52-week low intraday.
The stock is down 13.64% over the past five sessions and up 3.88% from its IPO price. It sits 21.73% below its 52-week high of US$23.88. Volume was 9.17 times its average.
The Nasdaq Composite is down 2.47% over the past five sessions and up 11.42% year to date.
Based on public media reports. AI-generated; not investment advice.
